5 Good Stocks to Buy Right Now

4. Novavax, Inc. (NASDAQ: NVAX)

Number of Hedge Fund Holders: 37

Novavax, Inc. (NASDAQ: NVAX) is a Maryland-based biotech company and it ranks 4th on the list of 15 good stocks to buy right now. Novavax, Inc. (NASDAQ: NVAX) stock has risen 26.4% in the previous month after the biotech company has stated that a single booster dosage of the COVID-19 vaccine NVX-CoV2373, is linked to a 4.6-fold increase in effective antibody response against the pandemic virus. 

Cantor Fitzgerald analyst Charles Duncan maintained an Overweight rating on Novavax, Inc. (NASDAQ: NVAX) with a price target of $272 per share on August 4, following the EU’s approval of an Advanced Purchase Agreement with Novavax for NVX-CoV2373. By the end of Q3 2021, Novavax, Inc. (NASDAQ: NVAX) aims to have a monthly manufacturing capacity of 100 million doses, and 150 million doses by the end of Q4 2021.

The company has a market cap of over $14 billion. In the second quarter of 2021, Novavax, Inc. (NASDAQ: NVAX) reported an EPS of -$4.75, missing estimates by $1.50. The company’s second-quarter revenue came in at $298.02 million, an increase of 738.5% year over year. The stock has gained 70%, year to date.